ICGEB CRP Grants remain one of the Organisation’s most popular programmes and enjoy worldwide recognition.
Read more
ICGEB CRP Grants remain one of the Organisation’s most popular programmes and enjoy worldwide recognition.
Read moreThe Biotech Development Unit has designed an online training module on the production process from the cell to the purified Active Pharmaceutical Ingredient. Access this rich eLearning platform.
Read moreTwo of the major institutes that comprise the Trieste Science System have partnered to support scientists from developing countries.
Read moreOn 16 December 2020, the Government of Angola acceded to the ICGEB Statutes to become the 66th Full Member State of the Organisation.
Read moreWednesday, 16 December 2020: the Interreg INCardio project kicks off. Lead Partner, ICGEB Trieste, together with the EURAC Research, Institute of Biomedicine, Medical University of Innsbruck, and the Carinthia University of Applied Sciences have launched an interregional project to promote European cooperation in cardiovascular research.
READ MoreOn the 15th of December 2020, ICGEB Cape Town celebrates the remarkable and record achievement of eight PhD graduates.
Read moreThe ICGEB Cancer Genomics Group is featured in the Swiss-South Africa Joint Research Programme (SSAJRP) publication, featuring two of the Groups collaborative projects, led by Dr Luiz Zerbini.
Read moreFederica Benvenuti form ICGEB Trieste, has been interviewed by the Journal Nature for the Where I work article series.
READ MoreICGEB HQ, Trieste: 18 and 19 November 2020, more than 110 delegates from across the globe review and discuss ICGEB’s Biotech research initiatives, its efforts in the battle against Covid19, developing partnerships and capacity building for sustainable development.
Read moreLa Notte dei Ricercatori: 27 November 2020, Sharper Night – event held in 13 cities across Italy for European Researchers’ Night. Tour our labs, meet, and chat online with our Researchers.
Read moreSyncona Ltd announces the foundation of a new Syncona company, Purespring Therapeutics (Purespring) with a £45.0 million holding, involving ICGEB Intellectual Property.
Read moreWith the support of New England Biolabs, the ICGEB Cape Town Component received SARS-CoV-2 Rapid Colorimetric LAMP assay kits.
Read more